BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences-September 2024-www.financetom.com

BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences

Jul 24, 2024 8:01 PM

July 25 (Reuters) - Peijia Medical Ltd ( PEJMF ):

* ACQUISITION OF COMPANY'S LICENSING PARTNER JENAVALVE

TECHNOLOGY,

INC. BY EDWARDS LIFESCIENCES ( EW )

* EDWARDS LIFESCIENCES TO ACQUIRE JENAVALVE BY WAY OF A

MERGER

Further company coverage:

Previous page： India Morning Newsletter, July 25 Next page： BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

India Morning Newsletter, July 25

Jul 24, 2024

To access a PDF version of this newsletter, please click here If you would like to receive this newsletter via email, please register at: https://solutions.refinitiv.com/MNCIndiaSubscriptionpage For an index of our newsletters click on ...

BRIEF-Peijia Medical Announces Acquisition Of Licensing Partner By Edwards Lifesciences

Jul 24, 2024

July 25 (Reuters) - Peijia Medical Ltd ( PEJMF ): * ACQUISITION OF COMPANY'S LICENSING PARTNER JENAVALVE TECHNOLOGY, INC. BY EDWARDS LIFESCIENCES ( EW ) * EDWARDS LIFESCIENCES TO ACQUIRE JENAVALVE BY WAY OF A MERGER Further company coverage: ...

Healthcare firm Concentra prices US IPO at nearly $3 billion valuation

Jul 24, 2024

(Reuters) - Concentra Group set the pricing of its U.S. initial public offering (IPO) at a valuation of $2.97 billion, the U.S. healthcare firm said on Wednesday. The company, which is a unit of Select Medical ( SEM ) , priced its IPO at $23.5 apiece, close to the lower end of its targeted range of $23 to $26. It...

Healthcare firm Concentra prices US IPO at nearly $3 bln valuation

Jul 24, 2024

July 24 (Reuters) - Concentra Group set the pricing of its U.S. initial public offering (IPO) at a valuation of $2.97 billion, the U.S. healthcare firm said on Wednesday. The company, which is a unit of Select Medical ( SEM ), priced its IPO at $23.5 apiece, close to the lower end of its targeted range of $23 to $26....